A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis

Status

Terminated

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00333996

Enrollment

Registered

2006-06-06

Start date

2006-05-31

Completion date

2007-03-31

Last updated

2011-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Uveitis

Brief summary

This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious anterior uveitis.

Interventions

DRUGDexamethasone

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years or older with a diagnosis of non-infectious anterior uveitis in at least one eye

Exclusion criteria

* Uncontrolled systemic disease * Any active ocular infections

Design outcomes

Primary

Measure	Time frame
Anterior Chamber Cell	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026